本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Esperion Therapeutics Inc.

3.72
+0.545017.19%
成交量:1,571.89萬
成交額:5,674.52萬
市值:8.88億
市盈率:-6.93
高:3.77
開:3.28
低:3.28
收:3.17
52周最高:3.94
52周最低:0.6925
股本:2.39億
流通股本:2.37億
量比:2.87
換手率:6.63%
股息:- -
股息率:- -
每股收益(TTM):-0.5358
每股收益(LYR):-0.2764
淨資產收益率:97.76%
總資產收益率:-5.42%
市淨率:-1.97
市盈率(LYR):-13.44

資料載入中...

2024/12/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/13

重要事件披露

Form 8-K - Current report
2024/11/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/07

重要事件披露

Form 8-K - Current report
2024/10/17

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/10/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/12

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/08/12

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/12

重要事件披露

Form 8-K - Current report
2024/08/05

重要事件披露

Form 8-K - Current report
2024/07/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/07/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/28

重要事件披露

Form 8-K - Current report
2024/06/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities